Article
The role of genetic testing in dyslipidaemia
14 Dec 2018
Abstract excerpt
Dyslipidaemias encompass about two dozen relatively rare monogenic disorders and syndromes for which the genetic basis has largely been defined. In addition, the complex polygenic basis of disturbed lipids and lipoproteins has been characterised in many patients, and has been shown to result from accumulation of many common polymorphisms with small effects on lipids. Genetic technologies, including dedicated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
